BNP PARIBAS FINANCIAL MARKETS - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U201. A total of 34 filers reported holding SYNTHETIC BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q2 2022$010.0%0.00%
Q1 2022$010.0%0.00%
Q4 2021$010.0%0.00%
Q3 2021$0
-100.0%
10.0%0.00%
Q2 2021$1,0000.0%10.0%0.00%
Q1 2021$1,00010.0%0.00%
Q4 2020$010.0%0.00%
Q3 2020$0
-100.0%
10.0%0.00%
Q2 2020$1,00010.0%0.00%
Q1 2020$010.0%0.00%
Q4 2019$010.0%0.00%
Q3 2019$0
-100.0%
10.0%0.00%
Q2 2019$1,0000.0%10.0%0.00%
Q1 2019$1,0000.0%10.0%0.00%
Q4 2018$1,000
-66.7%
10.0%0.00%
Q3 2018$3,00010.00%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Virtu Financial LLC 331,543$90,0000.01%
Sterneck Capital Management, LLC 25,000$7,0000.00%
Landmark Financial Advisors, LLC 24,200$7,0000.00%
Jacobi Capital Management LLC 18,500$5,0000.00%
MSD Partners, L.P. 349,290$96,0000.00%
Focused Wealth Management, Inc 500$00.00%
UBS Group AG 97,378$26,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 74,300$20,0000.00%
IFP Advisors, Inc 13,825$5,0000.00%
BNP PARIBAS FINANCIAL MARKETS 1$00.00%
View complete list of SYNTHETIC BIOLOGICS INC shareholders